Avis Budget Group, Inc.

More coverage

BrainChild hauls in $116M to make cell therapies for childhood brain cancers

Tech 16 d ago

Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns

Markets 23 d ago also on NVS

Johnson & Johnson (JNJ) Taps Sail Biomedicines in Bid for CAR-T Edge Over Bristol Myers Squibb

Markets 26 d ago also on JNJ BMY

Allogene Therapeutics: Is The Market Looking At CAR-T Persistence The Wrong Way?

Markets 26 d ago also on ALLO

Avis Budget Group put options surge as bearish signals mount

Markets 28 d ago

CAPREIT Announces August 2026 Distribution

Markets 37 d ago

5 Recession-Proof Stocks Hiding in Cardboard Boxes

Economy 38 d ago

Avis Budget Group EVP sells $652,574 in company stock

Markets 39 d ago 3 sources

Hemogenyx Pharmaceuticals (HEMO) Finalizes CAR-T Collaboration with Cellin Technologies for HG-CT-1 Therapy in Estonia

Markets 44 d ago also on LSE HG

CAR Group FY26 slides: AI drives double-digit growth across regions

Tech 45 d ago 3 sources

Sana Biotechnology faces earnings test as CAR-T program advances

Earnings 46 d ago 3 sources also on SANA

How Fair Value spotted Avis Budget’s 52% plunge four months early

Markets 47 d ago 3 sources